Takashi Oda

Dr. Takashi Oda

Department of Nephrology and Blood Purification, Kidney Disease Center, Tokyo Medical University Hachioji Medical Center, 1163 Tatemachi, Hachioji-shi, Tokyo 193-0998, Japan
orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2002 in Nature
Verified
Journal Article
Closed access
PDF file
Atsushi EnomotoAtsushi Enomoto
Atsushi Enomoto
HKHiroaki Kimura
Hiroaki Kimura
ACArthit Chairoungdua
Arthit Chairoungdua
YSYasuhiro Shigeta
Yasuhiro Shigeta
PJPromsuk Jutabha
Promsuk Jutabha
HEHitoshi Endou
Hitoshi Endou

1 December 2008 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
HMHirotaka Matsuo
Hirotaka Matsuo
TCToshinori Chiba
Toshinori Chiba
SNShushi Nagamori
Shushi Nagamori
Akiyoshi NakayamaAkiyoshi Nakayama
Akiyoshi Nakayama
HDHideharu Domoto
Hideharu Domoto
NSNariyoshi Shinomiya
Nariyoshi Shinomiya

1 August 2001 in Kidney International
Verified
Journal Article
Closed access
TOTakashi Oda
Takashi Oda
YJYoung Ok Jung
Young Ok Jung
HKHeung Soo Kim
Heung Soo Kim
XCXiaohe Cai
Xiaohe Cai
JLJesús M. López-Guisa
Jesús M. López-Guisa
AEAllison A. Eddy
Allison A. Eddy

1 July 2004 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
NYNobuyuki Yoshizawa
Nobuyuki Yoshizawa
KYKazuo Yamakami
Kazuo Yamakami
MFMasayuki Fujino
Masayuki Fujino
TOTakashi Oda
Takashi Oda
KTKikuko Tamura
Kikuko Tamura
MBMichael D.P. Boyle
Michael D.P. Boyle
The role of nephritis-associated antigen as a virulence factor for acute poststreptococcal glomerulonephritis (APSGN) remains to be fully clarified. Nephritis-associated plasmin receptor (NAPlr) was previously isolated from group A streptococcus (GAS) and shown to bind plasmin(ogen). The nucleotide sequence of the naplr gene from GAS isolates obtained from patients with APSGN was determined. The sequence of the putative open reading frame (1011 bp) showed 99.8% identity among isolated strains. Homology screen revealed an exact match with streptococcal glyceraldehyde-3-phosphate dehydrogenase (GAPDH). NAPlr exhibited GAPDH activity in zymography, and it activated the complement pathway in vitro. In APSGN kidney biopsy specimens, NAPlr was observed mainly in the early stage of the disease (1 to 14 d after onset) but was not colocalized with either C3 or IgG as assessed by double immunofluorescence staining. Sera of patients with APSGN, patients with GAS infection without renal involvement, nonrenal pediatric patients, and healthy adults as controls were assayed for anti-NAPlr antibody titers. Anti-NAPlr antibodies were present most frequently in APSGN sera, and antibody titers were also significantly higher than in patients with GAS infection alone or in other control patients. Moreover, antibody titers remained elevated during the entire 10-yr follow-up period.

1 August 2000 in Kidney International
Verified
Journal Article
Closed access
AEAllison A. Eddy
Allison A. Eddy
HKHeungsoo Kim
Heungsoo Kim
JLJesús López-Guisa
Jesús López-Guisa
TOTakashi Oda
Takashi Oda
PSPaul D. Soloway
Paul D. Soloway
DWDiane Wing
Diane Wing

1 April 2001 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
HKHeungsoo Kim
Heungsoo Kim
TOTakashi Oda
Takashi Oda
JLJesús López-Guisa
Jesús López-Guisa
DWDiane Wing
Diane Wing
DEDylan R. Edwards
Dylan R. Edwards
AEAllison A. Eddy
Allison A. Eddy
: Progressive renal disease as a result of renal fibrosis is caused in part by an impairment of the proteolytic machinery that normally regulates matrix turnover. The goal of the present study was to determine whether genetic deficiency of tissue inhibitor of metalloproteinases-1 (TIMP-1) could attenuate interstitial fibrosis caused by unilateral ureteral obstruction (UUO). Groups of wild-type (Timp-1) mice and TIMP-1—deficient (timp-1) mice were killed after 3 and 14 d of UUO or sham operation. Timp-1 mRNA levels were significantly increased 37- and 19-fold in the wild-type mice 3 and 14 d, respectively, after UUO operation. Matrix metalloproteinase-9 (MMP-9) activity fell in all UUO groups but remained significantly higher in the timp-1 group compared with the Timp-1 group. The degree of interstitial fibrosis (kidney collagen content and percentage of tubulointerstitial area stained with picrosirius red and collagen III) was significantly increased 14 d after UUO operation, but there was no difference between the Timp-1 and timp-1 groups. Many features of the fibrogenic response were similar between the Timp-1 and timp-1 groups, including the number of myofibroblasts and the induction of genes encoding procollagen III, fibronectin, and transforming growth factor-β. After UUO operation, renal mRNA levels for Timp-3 and plasminogen activator inhibitor-1 were significantly higher in the TIMP-1—deficient mice. The results of this study show that elimination of TIMP-1 alone does not alter the severity of interstitial fibrosis. These findings may be due to compensation by other protease inhibitors such as TIMP-2, TIMP-3, and/or plasminogen activator inhibitor-1 or to the possibility that inhibition of intrinsic MMP activity does not constitute a profibrogenic event in the kidney.